≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other specified/unspecified deforming dorsopathies

EFO MESH Endpoint Browser PheWeb

M13_DEFORMDORSONAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M43.8, M43.9
  • Hospital discharge: ICD-9 — 732[8-9]|737[8-9]
  • Hospital discharge: ICD-8 — 735
  • Cause of death: ICD-10 — M43.8, M43.9
  • Cause of death: ICD-9 — 732[8-9]|737[8-9]
  • Cause of death: ICD-8 — 735

2 out of 7 registries used, show all original rules.

728

4. Check minimum number of events

None

728

5. Include endpoints

None

728

6. Filter based on genotype QC (FinnGen only)

728

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6805 4430 2315
Only index persons 5608 3751 1857
Unadjusted period prevalence (%)
Whole population 0.11 0.13 0.06
Only index persons 0.12 0.14 0.07
Median age at first event (years)
Whole population 27.44 27.05 27.44
Only index persons 20.06 19.14 21.92

-FinnGen-

Key figures

All Female Male
Number of individuals 728 526 202
Unadjusted period prevalence (%) 0.15 0.18 0.09
Median age at first event (years) 21.31 17.19 32.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
658
Matched controls
6580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
73599
ICD-8 Finland
Other and unspecified curvature of spine
+∞
323.0
303
*
M43.9
ICD-10 Finland
Deforming dorsopathy, unspecified
+∞
90.8
85
*
7328A
ICD-9 Finland
Osteochondropathies, Other specified forms of osteochondropathy[JALKATERÄN YLIMÄÄRÄISTEN LUIDEN AIHEUTTAMAT OIREET]
+∞
77.7
73
*
7328B
ICD-9 Finland
Osteochondropathies, Other specified forms of osteochondropathy[MUIDEN YLIMÄÄRÄISTEN LUIDEN AIHEUTTAMAT OIREET]
+∞
76.6
72
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
28.4
66.4
91
37
9102
FHL
Trepanation or removal of the local bone process
61.2
65.5
76
14
M48.0
ICD-10 Finland
Spinal stenosis
35.4
54.2
70
22
M41.9
ICD-10 Finland
Scoliosis, unspecified
191.8
51.7
53
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
21.7
48.7
72
37
M43.1
ICD-10 Finland
Spondylolisthesis
57.5
45.3
53
10
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
52.8
41.3
49
10
9103
FHL
Partial or complete bone removal
422.2
40.6
40
*
N03AX12
ATC
gabapentin; oral
6.0
40.4
120
235
7373A
ICD-9 Finland
Curvature of spine, Kyphoscoliosis and scoliosis
+∞
40.0
38
*
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
+∞
37.9
36
*
M41.2
ICD-10 Finland
Other idiopathic scoliosis
+∞
34.7
33
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
19.4
34.2
52
29
M43.0
ICD-10 Finland
Spondylolysis
+∞
32.6
31
*
N02AX02
ATC
tramadol; systemic, rectal
2.9
32.5
274
1308
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
+∞
31.5
30
*
N03AX16
ATC
pregabalin; oral
3.7
31.4
158
519
7378X
ICD-9 Finland
Curvature of spine, Other curvatures of spine
+∞
30.4
29
*
M54.5
ICD-10 Finland
Low back pain
3.1
30.0
203
830
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
47.4
29.9
36
8
M43.8
ICD-10 Finland
Other specified deforming dorsopathies
+∞
29.4
28
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
5.5
27.3
85
173
M47.9
ICD-10 Finland
Spondylosis, unspecified
64.9
27.2
31
5
N06AX21
ATC
duloxetine; oral
4.8
26.6
94
220
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
+∞
26.2
25
*
M54.4
ICD-10 Finland
Lumbago with sciatica
4.5
25.0
95
239
7328X
ICD-9 Finland
Osteochondropathies, Other specified forms of osteochondropathy[OSTEOCHONDROPATHIAE ALIA DEFINITA]
+∞
24.1
23
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
20.4
22.3
33
17
M54.9
ICD-10 Finland
Dorsalgia, unspecified
5.2
21.9
70
146
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.9
20.8
53
83
L03
ICPC
Low back symptom/complaint
2.7
18.4
141
599
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
45.4
18.3
22
5
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
11.1
18.1
34
32
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
+∞
16.7
16
*
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
16.7
16
*
71798
ICD-8 Finland
Other nonarticular rheumatism, Other muscular rheumatism, fibrositis and myalgia
48.8
16.1
19
*
7329X
ICD-9 Finland
Osteochondropathies, Unspecified osteochondropathy
+∞
15.7
15
*
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
87.2
15.6
17
*
M47.82
ICD-10 Finland
Other spondylosis, cervical region
14.2
15.6
26
19
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
14.4
15.1
25
18
M03BX02
ATC
tizanidine; oral
1.9
14.7
392
2853
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
14.7
229
1358
M41.8
ICD-10 Finland
Other forms of scoliosis
+∞
14.6
14
*
72898
ICD-8 Finland
Vertebrogenic pain syndrome, Alia definita
+∞
14.6
14
*
N02AC04
ATC
dextropropoxyphene; oral
7.8
14.6
33
44
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.0
14.4
35
52
N02AA05
ATC
oxycodone; systemic
3.0
14.3
86
313
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
76.8
13.6
15
*
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
13.6
13
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
13.5
163
865
N06AA09
ATC
amitriptyline; systemic
3.4
12.9
63
197
M54.6
ICD-10 Finland
Pain in thoracic spine
4.9
12.6
41
88
73500
ICD-8 Finland
NA
+∞
12.5
12
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
12.5
12
*
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
+∞
12.5
12
*
N05BA04
ATC
oxazepam; oral
2.1
12.2
163
898
J01MA02
ATC
ciprofloxacin; systemic
1.9
12.2
236
1500
SPAT1229
SPAT
Assessment of need for aid
3.6
12.1
55
163
M01AB55
ATC
diclofenac, combinations; oral
3.8
12.0
51
143
M41
ICD-10 Finland
Scoliosis
47.6
11.9
14
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
15.0
11.8
19
13
M54.3
ICD-10 Finland
Sciatica
6.7
11.7
29
45
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
11.6
100
448
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.2
11.5
61
203
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
+∞
11.5
11
*
N05CF01
ATC
zopiclone; oral
1.9
11.5
203
1243
H02AB06
ATC
prednisolone; systemic
1.8
11.4
283
1943
M54.1
ICD-10 Finland
Radiculopathy
10.8
11.3
21
20
L86
ICPC
Back syndrome with radiating pain
5.0
11.3
36
76
M50.3
ICD-10 Finland
Other cervical disc degeneration
17.4
11.2
17
10
N06AX11
ATC
mirtazapine; oral
1.9
10.9
199
1228
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.6
10.8
48
140
R52.2
ICD-10 Finland
Other chronic pain
6.5
10.7
27
43
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
21.9
10.7
15
7
R06.0
ICD-10 Finland
Dyspnoea
2.1
10.7
136
728
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.7
10.6
22
26
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.0
10.6
62
222
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
10.4
10
*
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
+∞
10.4
10
*
N06AX16
ATC
venlafaxine; oral
2.4
10.4
95
439
M01AH02
ATC
rofecoxib; oral
2.7
10.4
73
293
M79.6
ICD-10 Finland
Pain in limb
1.8
10.4
205
1298
L02
ICPC
Back symptom/complaint
3.0
10.3
59
207
A02BA02
ATC
ranitidine; systemic
2.2
10.2
115
583
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
8.1
10.2
22
28
M01AH05
ATC
etoricoxib; oral
1.7
10.2
358
2706
L29
ICPC
Musculoskeletal sympt/complt other
3.2
10.1
52
170
R03AC02
ATC
salbutamol; inhalant
1.7
10.0
326
2403
72800
ICD-8 Finland
Vertebrogenic pain syndrome, Cervicalgia
40.7
10.0
12
*
L17
ICPC
Foot/toe symptom/complaint
2.0
9.9
138
767
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
12.4
9.9
17
14
M01AE51
ATC
ibuprofen, combinations; systemic
12.4
9.9
17
14
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
12.4
9.9
17
14
A02BC05
ATC
esomeprazole; systemic
1.8
9.9
242
1635
L28
ICPC
Limited function/disability (L)
2.4
9.8
86
390
9359
FHL
Other measure in this category
55.8
9.7
11
*
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
101.4
9.4
10
*
M41.3
ICD-10 Finland
Thoracogenic scoliosis
101.4
9.4
10
*
M41.5
ICD-10 Finland
Other secondary scoliosis
+∞
9.4
9
*
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
9.4
9
*
71310
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis cervicalis
+∞
9.4
9
*
71312
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis
+∞
9.4
9
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
9.3
139
790
R07.3
ICD-10 Finland
Other chest pain
2.8
9.3
59
222
R51.80
ICD-10 Finland
Headache
2.3
9.0
88
419
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.0
8.8
125
697
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
5.5
8.8
25
47
SPAT1240
SPAT
Therapeutic discussion
2.5
8.8
69
295
AA1AD
NOMESCO Finland
CT of head and brain
2.0
8.7
124
692
A02BC03
ATC
lansoprazole; oral
1.8
8.6
167
1038
A02BC01
ATC
omeprazole; systemic
1.8
8.6
161
990
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
8.6
170
1064
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
8.6
260
1850
72850
ICD-8 Finland
Vertebrogenic pain syndrome, Pain in thoracic spine
+∞
8.3
8
*
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
+∞
8.3
8
*
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
+∞
8.3
8
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
8.2
201
1340
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
8.2
62
259
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
8.1
216
1476
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.9
7.8
24
50
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
7.8
85
426
P03
ICPC
Feeling depressed
2.5
7.7
59
247
71300
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) coxae
45.5
7.7
9
*
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
45.5
7.7
9
*
J01DA01
ATC
[U] cefalexin; systemic
1.6
7.7
395
3192
SPAT1260
SPAT
Consultation of another employee
2.0
7.7
98
522
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.6
7.6
53
212
R52.1
ICD-10 Finland
Chronic intractable pain
25.3
7.6
10
*
A02BC02
ATC
pantoprazole; systemic
1.6
7.5
377
3022
M79.7
ICD-10 Finland
Fibromyalgia
4.9
7.5
23
48
M03BX01
ATC
baclofen; systemic
7.2
7.5
17
24
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
81.0
7.4
8
*
9193
FHL
Spondylodesis (also includes correction)
+∞
7.3
7
*
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
+∞
7.3
7
*
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
+∞
7.3
7
*
M01AX17
ATC
nimesulide; oral
1.8
7.3
133
809
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.2
214
1501
A02BA04
ATC
nizatidine; systemic
2.6
7.1
49
196
N03AE01
ATC
clonazepam; systemic
3.3
7.0
34
108
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
7.0
104
586
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.0
7.0
21
43
SPAT1301
SPAT
No procedures
1.7
7.0
162
1055
M01AB05
ATC
diclofenac; systemic, rectal
1.6
7.0
396
3240
M01AH01
ATC
celecoxib; oral (coxibs)
2.0
6.9
96
528
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
6.2
6.8
17
28
1220
FHL
Arthroscopy
3.2
6.7
33
107
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
6.7
98
554
SPAT1263
SPAT
Sampling
1.6
6.6
235
1715
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
6.6
70
345
N06AB04
ATC
citalopram; systemic
1.7
6.6
133
834
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.9
6.5
25
66
N06AX03
ATC
mianserin; oral
3.3
6.5
30
93
9211
FHL
Exploration or removal of diskusprolapse
70.5
6.4
7
*
J01EA01
ATC
trimethoprim; systemic
1.7
6.4
158
1048
M25.5
ICD-10 Finland
Pain in joint
1.7
6.4
159
1059
M70.6
ICD-10 Finland
Trochanteric bursitis
2.2
6.3
63
301
M01AC06
ATC
meloxicam; systemic, rectal
1.6
6.3
195
1370
N05BA01
ATC
diazepam; systemic, rectal
2.0
6.3
76
398
2309
FHL
Other measure in this category
+∞
6.3
6
*
M53.2
ICD-10 Finland
Spinal instabilities
+∞
6.3
6
*
9183
FHL
Posterolateral spondylodesis
+∞
6.3
6
*
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
+∞
6.3
6
*
G99.2*M47.9
ICD-10 Finland
Myelopathy in spondylosis
+∞
6.3
6
*
7233A
ICD-9 Finland
Other disorders of cervical region, Cervicobrachial syndrome (diffuse)
+∞
6.3
6
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.2
519
4589
N05AH04
ATC
quetiapine; oral
1.9
6.2
96
553
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
7.8
6.1
13
17
A06AD11
ATC
lactulose; oral
2.1
6.1
71
366
G44.2
ICD-10 Finland
Tension-type headache
2.1
6.1
72
372
NF1AA
NOMESCO Finland
Hip X-ray examination
2.6
6.0
41
164
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
6.0
137
886

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
288
1903
1.85
13.87
8.6
8.1
inr
1.2
1.2
0.01
92
611
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
316
2183
1.79
12.90
6.4
5.4
mmol/l
1.2
1.2
1.23
286
1980
(3042936) Bacteria identified in Isolate by Culture
129
682
2.08
11.77
2.5
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
240
1565
1.80
11.64
2.6
2.3
u/l
57.5
58.5
0.08
226
1461
(3018418) pH of Serum or Plasma
220
1426
1.78
10.74
4.0
3.7
ph
7.4
7.4
0.11
41
289
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
223
1452
1.77
10.72
2.8
2.0
u/l
180.5
188.5
0.07
211
1356
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
363
2738
1.65
9.90
6.6
6.1
umol/l
10.5
11.1
0.40
349
2592
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
334
2473
1.65
9.75
7.3
6.2
mmol/l
1.2
1.2
1.34
279
2063
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
192
1242
1.74
9.24
3.3
3.1
ng/l
864.7
1246.8
0.97
155
1043
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
505
4199
1.66
8.89
8.7
6.9
u/l
76.0
76.5
0.13
483
3952
(3031040) Bacteria [#/volume] in Urine by Automated count
426
3422
1.59
8.41
5.7
3.7
e6/l
12.8
2919.7
—
5
59
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
147
904
1.78
8.35
1.4
1.2
u/ml
20.7
12.0
0.56
60
357
(3013707) Erythrocyte sedimentation rate by Westergren method
489
4070
1.61
8.21
5.3
3.5
mm/h
10.6
11.4
0.74
455
3778
(3037467) Urinalysis macro (dipstick) panel - Urine
449
3667
1.59
8.13
5.5
3.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
183
1206
1.69
8.11
4.7
4.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
304
2299
1.55
7.54
2.5
2.1
nmol/l
76.5
76.1
0.08
268
2109
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
241
1734
1.58
7.41
3.7
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
150
971
1.69
7.01
1.4
1.2
iu/ml
39.6
32.1
0.30
59
314
(3013826) Glucose [Moles/volume] in Serum or Plasma
365
2904
1.52
6.99
5.8
4.1
mmol/l
6.6
6.7
0.37
345
2715
(3024561) Albumin [Mass/volume] in Serum or Plasma
284
2157
1.52
6.70
5.3
4.4
g/l
35.8
36.0
0.25
257
2009
(3019060) Gas panel - Arterial blood
53
246
2.25
6.68
4.7
5.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
240
1760
1.54
6.65
8.4
5.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
180
1245
1.59
6.42
1.4
1.2
u/ml
3.9
1.6
0.62
49
330
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
136
881
1.67
6.30
3.9
3.1
ng/l
277.0
354.7
0.21
96
608
(3026008) Bacteria identified in Urine by Culture
203
1450
1.55
6.28
3.7
2.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
115
715
1.72
6.20
1.8
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
476
1.86
6.17
1.8
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
185
1300
1.57
6.13
3.3
2.6
e6/l
0.3
0.4
0.68
141
954
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
83
471
1.86
6.07
1.8
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
182
1277
1.57
6.06
3.3
2.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
23
5.29
6.02
2.8
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
102
630
1.72
5.62
2.8
2.3
%
24.0
23.0
0.31
84
540
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
161
1118
1.57
5.57
1.6
1.7
pmol/l
447.4
27885038.9
1.28
135
936
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
1091
1.56
5.40
4.5
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
326
2625
1.44
5.40
4.8
3.1
estimate
0.0
0.0
0.00
60
478
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
302
2398
1.44
5.39
4.2
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
90
543
1.75
5.38
1.8
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
235
1781
1.47
5.35
3.7
3.3
mmol/l
2.3
2.4
0.78
207
1598
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
244
1863
1.47
5.35
3.8
3.1
ng/l
20.1
60.6
1.20
165
1146
(3000850) Epithelial cells [#/volume] in Urine
145
993
1.57
5.31
2.9
2.3
e6/l
5.5
7.5
0.84
123
875
(3009261) Glucose [Presence] in Urine by Test strip
328
2664
1.42
5.09
4.7
3.1
estimate
0.0
0.0
0.80
60
468
(3004789) Transferrin [Mass/volume] in Serum or Plasma
107
688
1.65
5.06
2.7
2.2
g/l
2.4
2.4
0.29
99
637
(3019198) Lymphocytes [#/volume] in Blood
338
2764
1.42
5.02
7.8
5.6
e9/l
1.9
1.9
0.08
303
2466
(3006315) Basophils [#/volume] in Blood
330
2697
1.41
4.87
7.7
5.7
e9/l
0.0
0.0
0.46
295
2356
(3029937) Albumin [Presence] in Urine by Test strip
184
1350
1.49
4.87
5.6
3.3
estimate
0.0
0.0
0.69
62
476
(3026782) Osmolality of Urine
139
962
1.55
4.84
3.1
2.4
mosm/kgh2o
525.7
551.1
0.63
116
832
(3026493) Urate [Moles/volume] in Serum or Plasma
183
1347
1.48
4.75
3.0
2.4
umol/l
2822.8
4863.4
0.34
156
1195
(3018095) Leukocytes [#/volume] in Urine
228
1751
1.44
4.75
4.4
3.1
e6/l
76.1
121.5
0.65
164
1189
(3001604) Monocytes [#/volume] in Blood
328
2690
1.40
4.69
7.6
5.7
e9/l
0.6
0.6
0.20
294
2348
(3007164) IgA [Mass/volume] in Serum or Plasma
153
1089
1.51
4.67
1.5
1.5
g/l
2.2
2.3
0.36
93
695
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
148
2.29
4.57
1.2
1.3
ug/g
246.8
305.2
0.95
17
84
(3048689) Calprotectin [Mass/mass] in Stool
104
683
1.61
4.52
2.3
2.2
ug/g
100.2
123.3
0.36
87
548
(3021601) Nitrite [Presence] in Urine by Test strip
323
2656
1.39
4.49
6.4
4.4
estimate
0.0
0.0
0.41
61
488
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
622
5743
1.57
4.43
17.3
11.2
mg/l
22.2
22.1
0.01
509
4417
(3002582) Erythrocytes [#/volume] in Urine
194
1466
1.44
4.35
3.5
2.7
e6/l
39.8
103.9
0.69
149
1103
(3013115) Eosinophils [#/volume] in Blood
337
2802
1.38
4.33
8.0
6.0
e9/l
0.2
0.2
0.04
305
2482
(3019550) Sodium [Moles/volume] in Serum or Plasma
635
5900
1.60
4.30
18.0
12.5
mmol/l
139.6
139.7
0.63
620
5733
(3037522) Nuclear Ab [Titer] in Serum
113
766
1.56
4.30
1.5
1.3
titre
529.1
518.5
0.03
22
160
(3022217) INR in Platelet poor plasma by Coagulation assay
83
522
1.67
4.28
24.0
19.5
inr
1.4
1.2
—
10
84
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
153
2.21
4.24
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
209
1611
1.42
4.18
2.4
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
105
704
1.57
4.18
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
57
3.03
4.14
1.3
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
370
3146
1.36
4.03
11.1
9.3
e9/l
4.1
4.0
0.20
334
2757
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
261
2102
1.38
4.01
5.0
3.2
—
—
—
0
0
(3013512) EKG study
193
1478
1.42
3.99
3.9
3.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
89
581
1.61
3.97
2.6
2.5
umol/l
9.9
7.1
0.42
72
495
(3022948) Iron [Moles/volume] in Serum or Plasma
110
756
1.54
3.93
2.8
2.2
umol/l
13.8
13.2
0.42
101
696
(3017143) Hepatitis C virus Ab [Presence] in Serum
90
592
1.59
3.89
1.8
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
635
5929
1.56
3.87
18.3
12.6
mmol/l
3.9
3.9
0.61
619
5751
(3002030) Lymphocytes/100 leukocytes in Blood
317
2646
1.35
3.83
8.1
5.8
%
28.1
28.3
0.12
299
2476
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
114
2.33
3.82
1.6
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
149
1098
1.45
3.78
5.2
3.3
kg/l
1.0
1.0
0.56
23
154
(40757373) Influenza virus identified in Isolate
7
8
8.82
3.78
1.6
2.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
313
2615
1.35
3.73
7.8
5.6
%
57.5
57.1
0.23
299
2461
(3019069) Monocytes/100 leukocytes in Blood
308
2568
1.35
3.72
8.1
6.0
%
8.4
8.4
0.10
293
2411
(3003458) Phosphate [Moles/volume] in Serum or Plasma
91
611
1.56
3.61
6.4
5.2
mmol/l
1.0
1.0
0.39
81
572
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
72
460
1.63
3.52
2.2
2.0
u/l
65.6
37.4
0.40
62
397
(3006504) Eosinophils/100 leukocytes in Blood
305
2555
1.33
3.51
7.9
5.7
%
2.9
2.8
0.21
286
2379
(3021960) Folate [Moles/volume] in Serum or Plasma
149
1113
1.43
3.50
1.5
1.4
nmol/l
20.6
21.3
0.20
127
945
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
56
336
1.72
3.46
1.8
1.6
—
—
—
0
0
(3020891) Body temperature
33
167
2.02
3.44
4.1
4.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
64
399
1.66
3.44
2.2
2.8
g/l
10.3
10.6
0.20
55
368
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
230
1854
1.35
3.41
3.8
3.2
u/l
29.4
30.7
0.31
217
1776
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
583
5391
1.41
3.36
5.7
4.6
mu/l
1.9
2.1
0.45
535
4991
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
21
89
2.40
3.34
1.5
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
156
2.03
3.29
1.2
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
33
170
1.99
3.29
2.4
4.1
mmol/l
24.4
25.1
1.14
27
161
(3000991) Gas panel - Venous blood
58
357
1.68
3.28
10.8
7.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
295
2478
1.32
3.28
8.1
5.7
%
0.7
0.7
0.09
279
2306
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
129
2.14
3.27
2.7
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
75
494
1.58
3.24
3.1
4.4
ug/l
14.7
8.6
0.29
53
388
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
259
1.79
3.22
1.6
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
156
1192
1.39
3.21
2.1
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
502
4549
1.33
3.18
4.8
4.0
pmol/l
14.7
14.5
0.55
463
4207
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
157
1205
1.39
3.14
1.7
1.7
mg/l
1.0
1.1
0.02
111
900
(3003396) Base excess in Arterial blood by calculation
72
475
1.57
3.10
10.5
7.8
mmol/l
1.6
1.3
0.53
61
380
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
153
2.00
3.09
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
41
233
1.80
3.07
2.1
2.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
120
2.12
3.01
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
56
354
1.63
2.88
4.0
3.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
58
370
1.62
2.88
3.0
3.3
ng/l
76.9
76.1
0.04
50
322
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
239
1982
1.31
2.83
2.1
1.8
pmol/l
97.4
97.9
0.05
120
1044
(3044941) Cell count panel - Synovial fluid
17
71
2.43
2.82
1.7
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
36
203
1.81
2.78
3.2
2.8
mmol/l
24.5
23.9
0.39
28
186
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
181
1.86
2.78
2.2
1.9
u/l
1318.1
2268.4
0.31
11
67
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
69
465
1.53
2.73
2.1
2.1
g/l
0.2
0.2
0.94
62
445
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
79
2.31
2.69
1.3
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
81
568
1.48
2.66
8.7
5.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
12
43
2.82
2.65
1.5
2.3
umol/l
4.0
7.2
—
7
27
(3009508) Creatinine [Moles/volume] in Urine
187
1511
1.32
2.65
3.0
3.3
mmol/l
7.2
7.5
0.51
157
1285
(44790047)
15
61
2.49
2.63
1.7
1.7
—
—
—
0
0
(44806118)
15
61
2.49
2.63
1.7
1.7
—
—
—
0
0
(44790049)
15
61
2.49
2.63
1.7
1.7
—
—
—
0
0
(44790048)
15
61
2.49
2.63
1.7
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
187
1515
1.32
2.60
1.4
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
7
7.18
2.55
3.0
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
11
5.49
2.55
1.5
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
62
415
1.54
2.54
3.6
2.9
mmol/l
3.0
1.8
1.92
53
326
(3012095) Magnesium [Moles/volume] in Serum or Plasma
108
808
1.40
2.51
5.0
3.3
mmol/l
0.8
0.8
0.22
100
765
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
82
2.23
2.49
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
49
312
1.61
2.48
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
257
1.67
2.48
2.2
3.8
mmol/l
1.4
2.1
1.05
31
201
(3049717) Cytology report of Urine Cyto stain
28
152
1.88
2.46
2.5
2.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
124
1.97
2.43
1.6
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
213
1.73
2.40
17.5
11.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
153
1219
1.32
2.38
2.6
2.0
mg/l
3.0
3.0
0.11
133
1039
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
118
1.98
2.38
1.6
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
8
6.28
2.37
2.0
2.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
46
2.64
2.37
1.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
84
2.17
2.36
1.9
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
116
889
1.36
2.33
3.3
2.7
mmol/l
2.4
2.4
0.14
105
792
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
113
1.98
2.27
1.3
1.5
—
—
—
0
0
(4010399)
54
361
1.54
2.25
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
85
623
1.41
2.23
1.7
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
60
2.36
2.23
1.4
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
9
5.58
2.21
1.2
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
19
3.71
2.15
1.9
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
98
742
1.37
2.13
3.0
2.3
e6/l
0.6
1.2
3.70
54
395
(3009343) pH of Capillary blood
42
269
1.60
2.11
2.2
3.8
ph
7.4
7.4
—
5
35
(3008898) HLA-B27 [Presence]
32
191
1.71
2.10
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
68
487
1.44
2.04
2.4
2.9
%
1.6
1.8
0.93
60
438
(3029075) Extractable nuclear Ab panel - Serum
6
15
4.02
2.04
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
304
1.55
2.03
1.2
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
25
140
1.81
2.03
1.7
1.2
u/ml
1.9
13.9
—
6
25
(3041096) Erythrocytes [Presence] in Urine by Automated
187
1561
1.27
2.03
4.5
2.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
157
1283
1.29
2.02
4.3
3.4
%
88.2
94.1
1.95
150
1252
(3019309) Folate [Moles/volume] in Red Blood Cells
108
838
1.34
2.02
2.0
1.7
nmol/l
1217.0
1172.2
0.20
82
630
(3002385) Erythrocyte distribution width [Ratio]
526
4913
1.25
2.01
19.9
14.1
%
13.8
13.6
0.96
514
4814
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
59
414
1.46
1.97
3.7
3.4
mmol/l
1.2
1.2
0.66
50
355
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
98
752
1.35
1.97
1.7
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
51
2.38
1.96
1.1
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
11
4.57
1.94
4.4
3.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
71
2.14
1.93
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
73
536
1.40
1.92
2.0
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
92
1.98
1.91
1.8
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
424
3895
1.21
1.79
4.0
3.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
29
2.78
1.79
3.0
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
643
6184
1.34
1.78
15.5
10.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
193
1.63
1.77
2.1
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
92
712
1.33
1.76
3.2
2.4
e6/l
2.7
3.4
0.35
46
369
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
80
607
1.36
1.75
2.0
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
54
2.24
1.74
2.0
1.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
12
54
2.24
1.74
1.1
1.4
nmol/l
—
0.6
—
0
5
(3022313) Gas panel - Capillary blood
32
202
1.61
1.74
2.4
3.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
5
13
3.86
1.71
1.4
1.2
g/l
49.4
40.5
—
5
7
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
172
1.65
1.69
1.9
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
63
462
1.40
1.69
2.1
1.9
nmol/l
348.9
381.5
0.45
54
432
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
29
180
1.64
1.69
1.6
1.9
g/l
1.6
1.5
0.33
23
157
(3040151) Glucose [Moles/volume] in Capillary blood
10
42
2.40
1.68
12.5
9.0
mmol/l
6.0
6.8
—
10
36
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
150
1.69
1.65
1.5
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
55
397
1.42
1.62
3.9
4.2
%
0.3
0.6
0.63
13
89
(3009445) Proteinase 3 Ab [Units/volume] in Serum
33
214
1.57
1.62
1.1
1.6
—
11.4
—
0
5
(3024932) HLA-DR beta [Type]
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
13
63
2.08
1.60
14.3
5.8
mg/l
10.9
10.6
0.09
13
57
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
167
1.64
1.60
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
407
1.41
1.59
2.2
2.4
ml/min/173m2
72.6
67.8
0.54
26
160
(3021879) Hepatitis B virus core Ab [Presence] in Serum
54
390
1.42
1.59
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
107
861
1.28
1.56
4.0
3.6
%
20.3
21.5
0.32
40
370
(3001122) Ferritin [Mass/volume] in Serum or Plasma
282
2518
1.20
1.55
3.2
2.6
ug/l
99.3
105.2
0.31
264
2349
(40767503) Oxygen content in Capillary blood by calculation
15
78
1.94
1.55
1.5
2.4
%
15.8
16.6
—
6
45
(3043409) Potassium [Moles/volume] in Arterial blood
22
130
1.71
1.54
3.5
3.7
mmol/l
3.6
3.9
1.77
22
116
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
33
2.44
1.54
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
309
1.45
1.51
1.1
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
21
2.87
1.51
1.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
21
2.87
1.51
1.2
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
277
2478
1.19
1.48
11.7
8.5
e9/l
0.0
0.0
1.08
233
2050
(3021440) Promyelocytes/100 leukocytes in Blood
56
413
1.39
1.48
4.7
4.4
%
0.1
0.2
0.77
16
111
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
87
1.86
1.47
1.2
1.9
g/l
0.5
0.9
1.02
11
61
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
50
363
1.41
1.45
2.2
2.2
ug/l
36.6
7.5
0.88
43
320
(40758558) Short blood count panel - Blood
159
1353
1.22
1.44
9.1
6.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
60
451
1.36
1.42
1.1
1.2
iu/ml
124.8
142.7
0.16
20
200
(3025159) Blasts/100 leukocytes in Blood
53
391
1.38
1.41
4.8
4.5
%
0.6
1.0
0.17
14
93
(3037121) Protein [Mass/volume] in Urine
27
174
1.57
1.39
3.9
3.5
g/l
0.1
0.2
2.66
11
72
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
590
5656
1.23
1.38
4.5
4.0
mmol/l
5.8
5.8
0.63
547
5203
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
41
2.21
1.37
1.8
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
120
1.69
1.35
2.5
2.7
u/ml
0.4
0.4
—
10
65
(3025130) Human papilloma virus identified in Specimen
16
90
1.80
1.34
1.3
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
60
456
1.34
1.34
5.3
3.3
—
—
—
0
0
(4062490)
11
54
2.05
1.33
1.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
58
439
1.35
1.33
4.6
4.3
%
0.4
1.1
1.61
16
126
(40760892) CBC W Ordered Manual Differential panel - Blood
153
1310
1.21
1.30
4.8
4.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
106
1.72
1.30
1.1
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
163
1405
1.21
1.30
3.1
3.3
mg/l
858.2
469.7
0.29
102
888
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
18
2.79
1.28
1.2
2.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
48
2.10
1.28
1.2
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
53
695
0.74
1.28
1.7
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
55
2.02
1.28
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
229
2555
0.85
1.27
2.7
2.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
77
1.83
1.26
1.2
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
131
1.62
1.24
2.5
2.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
33
229
1.46
1.24
2.1
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
488
0.70
1.24
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
85
1.78
1.23
1.5
1.3
u/ml
101.4
100.8
—
5
18
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
27
180
1.52
1.22
2.4
3.6
u/ml
1342.3
1820.0
0.11
19
157
(40768804) Tissue Pathology biopsy report
262
2365
1.17
1.22
2.0
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
19
2.64
1.22
1.2
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
66
518
1.30
1.20
4.0
2.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
94
1.72
1.18
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
94
1.72
1.18
1.6
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
72
1.82
1.15
2.6
3.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
39
2.06
1.15
2.6
1.5
promille
1.3
1.2
—
8
31
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
20
2.51
1.15
2.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
435
4091
1.16
1.15
3.4
2.8
u/l
41.1
45.4
0.77
409
3857
(4094501)
8
152
0.52
1.15
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
95
1.70
1.14
1.3
2.0
g/l
114.5
130.9
1.13
11
78
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
65
1.86
1.14
2.7
2.2
u/ml
13.3
67.3
0.41
12
60
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
30
209
1.45
1.12
4.4
3.1
%
42.8
48.9
0.89
30
203
(3016879) Cocaine [Presence] in Urine
26
176
1.49
1.11
1.9
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
51
1.97
1.11
1.1
1.5
nmol/l
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
31
2.27
1.10
2.1
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
21
2.39
1.09
1.6
1.0
iu/ml
199.4
129.2
—
5
21
(3020682) Albumin/Creatinine [Ratio] in Urine
170
1495
1.18
1.08
3.9
4.0
mg/mmol
4.3
7.6
1.45
112
940
(40760888) Immunoglobulin light chains.free panel - Serum
17
105
1.63
1.07
2.8
3.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
33
2.13
1.05
3.1
2.2
e6/l
573.6
458.3
—
7
27
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
98
1.65
1.04
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
57
449
1.29
1.03
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
50
387
1.31
1.02
2.3
2.7
e9/l
4.0
4.0
0.00
37
318
(3023419) Bacteria identified in Sputum by Culture
10
53
1.90
1.01
1.6
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
125
1077
1.19
1.01
5.1
4.2
ug/l
3.4
2.4
0.39
108
970
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
91
1.66
1.01
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
99
1.63
1.00
1.3
1.2
u/ml
263.1
318.5
0.50
11
56
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
1.6
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
23
2.18
0.98
1.4
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
27
190
1.44
0.98
1.9
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
190
1.44
0.98
1.9
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
645
6289
1.22
0.97
12.1
9.0
u/l
25.3
25.6
0.19
629
6088
(3020630) Protein [Mass/volume] in Serum or Plasma
47
364
1.31
0.97
2.4
2.9
g/l
66.6
67.3
0.23
40
343
(3020779) Urea [Moles/volume] in Serum or Plasma
51
400
1.30
0.96
11.8
7.3
mmol/l
9.4
9.0
0.13
51
378
(3027008) Opiates [Presence] in Urine
27
191
1.43
0.96
1.9
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
51
1.77
0.94
1.8
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
37
1.90
0.94
1.0
1.2
—
—
—
0
0
(44813793)
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
120
0.50
0.94
1.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
120
0.50
0.94
1.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
120
0.50
0.94
1.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
120
0.50
0.94
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
27
192
1.42
0.93
1.9
2.0
—
—
—
0
0
(3019225) pH of Specimen
61
492
1.26
0.93
3.3
4.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
675
6619
1.27
0.92
24.0
16.8
e9/l
261.5
257.2
0.95
663
6448
(3005322) IgE [Units/volume] in Serum or Plasma
47
367
1.30
0.92
1.3
1.3
u/ml
75.0
212.6
2.52
42
338
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
78
1.68
0.92
1.7
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
28
2.15
0.91
1.2
1.3
—
101.4
—
0
7
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
94
1.61
0.91
1.7
2.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
23
160
1.45
0.90
1.5
1.7
—
86.7
—
0
6
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
42
1.91
0.88
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
42
1.91
0.88
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
42
1.91
0.88
1.4
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
675
6623
1.26
0.88
23.9
16.8
fl
91.1
90.7
1.80
668
6521
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
144
1.47
0.88
1.1
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
56
1.80
0.88
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
675
6624
1.26
0.87
24.0
16.8
e12/l
4.5
4.5
2.44
663
6440
(3035941) MCH [Entitic mass]
675
6624
1.26
0.87
23.9
16.7
pg
30.3
30.2
0.51
668
6522
(3010813) Leukocytes [#/volume] in Blood
675
6624
1.26
0.87
24.1
16.9
e9/l
6.7
6.6
0.32
664
6434
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(4027681)
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
64
1.73
0.86
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
44
345
1.29
0.85
2.0
3.2
e9/l
69.1
71.3
0.19
34
265
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
19
129
1.49
0.84
1.3
1.4
u/l
27.4
29.1
0.09
14
110
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
57
1.76
0.84
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
675
6628
1.25
0.83
24.2
16.9
g/l
134.0
135.4
1.91
669
6526
(3022145) Colonoscopy Study observation
72
601
1.22
0.83
1.4
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
2.7
2.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
32
1.88
0.82
1.3
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
81
1.62
0.81
2.3
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
66
1.68
0.79
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
48
1.67
0.79
1.4
1.7
mosm/kgh2o
278.8
282.6
—
8
37
(3004588) Protein electrophoresis panel - Serum or Plasma
39
306
1.29
0.76
2.2
2.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
91
1.55
0.75
4.4
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
108
946
1.17
0.75
2.2
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
54
443
1.24
0.74
1.6
1.3
iu/l
26.4
31.0
0.46
48
387
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
54
1.67
0.74
1.8
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
55
1.64
0.73
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
107
0.56
0.73
1.5
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
40
1.76
0.71
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
109
1.48
0.71
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
45
364
1.25
0.71
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
71
603
1.20
0.71
1.6
1.7
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
26
1.93
0.70
2.0
3.3
mu/l
46.7
29.9
—
5
26
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
93
1.52
0.70
1.1
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
164
1489
1.13
0.69
1.8
1.6
mmol/l
1.3
1.4
0.53
142
1262
(4034850)
21
153
1.38
0.67
7.2
6.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
94
1.50
0.67
1.4
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
43
1.63
0.67
2.0
2.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
70
1.58
0.65
1.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
70
1.58
0.65
1.1
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
44
1.60
0.65
1.6
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
163
1.36
0.65
2.3
3.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.4
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
208
1.31
0.63
1.3
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
39
316
1.25
0.62
2.4
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
71
1.56
0.62
1.1
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
50
1.61
0.61
2.0
3.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.7
—
33.9
—
0
16
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
32.8
—
0
22
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
1.1
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
53
1.51
0.58
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
53
1.51
0.58
1.4
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
319
1.24
0.58
3.0
2.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
81
710
1.16
0.58
1.8
1.8
%
1.4
1.4
0.00
67
643
(3001019) Free T4 and TSH panel - Serum or Plasma
39
472
0.82
0.57
1.6
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
36
1.67
0.56
2.3
1.5
%
10.4
10.5
—
6
36
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
36
1.67
0.56
1.3
1.2
—
70.0
—
0
6
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
36
1.67
0.56
2.2
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
55
1.46
0.56
2.8
2.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
65
1.55
0.55
1.5
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
38
1.58
0.54
2.3
3.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
36
296
1.23
0.52
2.9
2.3
nmol/l
12.7
12.7
0.01
31
275
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
63
1.43
0.52
1.4
3.8
u/ml
19.8
76.8
—
9
63
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
77
681
1.15
0.50
4.6
3.9
%
32.6
31.8
0.25
51
470
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
199
1.27
0.48
1.7
2.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
93
1.41
0.48
1.3
3.0
kpa
7.8
8.2
0.34
13
87
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
93
1.41
0.48
1.1
1.2
u/ml
1.4
4.3
—
5
31
(3021901) Oxygen saturation in Capillary blood
11
76
1.45
0.48
1.4
2.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
137
1.32
0.47
2.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
68
1.48
0.47
1.1
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
68
1.48
0.47
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
68
1.48
0.47
1.1
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
85
1.42
0.47
4.0
3.3
—
3206.4
—
0
8
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
48
1.46
0.47
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
50
1.40
0.45
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
50
1.40
0.45
5.6
3.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
69
1.46
0.44
1.5
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
69
1.46
0.44
1.1
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
239
1.22
0.43
2.4
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
212
1.23
0.42
2.2
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
85.9
—
0
8
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
59
1.36
0.41
1.6
1.3
mu/l
17.9
43.7
—
8
53
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
60
1.34
0.40
1.4
1.3
pmol/l
333.9
311.0
—
8
45
(3009542) Hematocrit [Volume Fraction] of Blood
564
5534
1.09
0.39
18.2
12.1
%
39.3
40.0
0.99
417
4294
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.4
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
9.6
7.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
544
5331
1.08
0.39
5.8
5.0
mmol/mol
39.4
39.2
0.13
506
4982
(3034770) Mitochondria Ab [Titer] in Serum
18
142
1.27
0.39
1.2
1.2
—
386.0
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
89
1.35
0.38
1.3
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
117
1085
1.09
0.36
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
190
1.22
0.35
1.2
1.4
miu/ml
172.4
244.1
—
5
96
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
43
1.40
0.35
1.2
3.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
71
644
1.11
0.34
3.2
2.6
ug/l
0.6
0.8
1.66
42
380
(3000330) Specific gravity of Urine by Test strip
28
237
1.19
0.34
3.6
3.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
145
1.25
0.34
2.1
2.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
100
1.31
0.33
2.1
1.4
—
—
—
0
0
(4024509)
6
46
1.31
0.33
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
74
1.36
0.32
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
83
1.33
0.32
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
75
1.34
0.30
1.4
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
55
1.28
0.30
1.4
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
130
0.77
0.29
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
80
738
1.09
0.29
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
56
1.25
0.29
1.1
3.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
94
1.28
0.28
2.3
1.8
pmol/l
172.1
217.5
0.80
12
89
(1616796) Gas panel - Central venous blood
12
94
1.28
0.28
4.1
3.7
—
—
—
0
0
(4268621)
8
62
1.29
0.28
2.0
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
77
1.30
0.26
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
63
580
1.09
0.25
1.7
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
78
1.29
0.24
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
122
1158
1.06
0.23
1.7
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
438
1.10
0.23
1.7
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
162
1.18
0.23
1.3
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
39
1.28
0.23
2.0
1.2
mmol/l
2.0
2.0
—
5
39
(3015183) Erythrocyte sedimentation rate
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
181
1.16
0.22
1.6
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
91
0.77
0.22
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
94
0.74
0.22
1.4
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.4
—
14.4
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
3.3
—
0.9
—
0
10
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
4.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
43
1.16
0.21
1.6
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
48
1.25
0.20
1.5
2.0
—
—
—
0
0
(44806071)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.2
—
12.4
—
0
9
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
49
1.23
0.20
1.3
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
6
50
1.20
0.19
1.3
1.1
nmol/l
427.2
474.3
—
6
42
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
410
4030
1.04
0.19
3.2
3.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
60
1.17
0.18
3.9
1.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
66
0.76
0.17
1.0
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
101
1.19
0.16
1.2
1.2
u/ml
1.3
3.9
—
7
39
(1002224) Polysomnography panel
27
298
0.90
0.16
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
139
1.15
0.16
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
564
5588
1.04
0.16
15.0
10.3
ml/min/173m2
84.5
83.6
0.50
472
4601
(3023511) Choriogonadotropin [Units/volume] in Urine
13
111
1.17
0.16
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
102
1.18
0.15
2.1
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
159
1.14
0.15
1.7
1.9
g/l
8.6
10.9
2.25
13
141
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
61
644
0.94
0.14
1.2
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
122
1.15
0.14
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
122
1.15
0.14
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
284
0.91
0.13
1.9
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
94
1.17
0.13
3.8
2.9
e9/l
3.5
4.3
0.58
11
94
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
161
1.12
0.13
1.7
1.9
g/l
3.4
3.1
0.40
13
130
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
258
1.09
0.12
1.5
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
158
0.88
0.12
2.6
2.1
iu/l
3.1
6.4
—
6
61
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
605
6012
1.04
0.12
4.7
4.3
mmol/l
2.8
2.9
1.02
560
5594
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
241
1.08
0.10
1.3
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
173
1.10
0.10
1.7
1.9
g/l
7.7
7.4
0.19
13
132
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
173
1.10
0.10
1.7
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
173
1.10
0.10
1.7
1.9
g/l
3.4
3.8
0.69
13
125
(40768793) Breast Pathology biopsy report
20
183
1.10
0.10
1.5
1.3
—
—
—
0
0
(4146454)
5
44
1.14
0.10
3.8
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
22
203
1.09
0.09
1.5
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
568
5713
0.97
0.09
3.9
3.6
mmol/l
1.3
1.3
0.07
528
5300
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
17
155
1.10
0.09
2.7
2.3
g/l
4.0
3.6
0.34
17
147
(3037756) Immunofixation for Serum or Plasma
11
97
1.14
0.09
1.2
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
146
1.10
0.08
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
595
5922
1.03
0.08
4.4
4.0
mmol/l
4.7
4.8
1.46
556
5547
(4281824)
7
67
1.05
0.08
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
98
1.12
0.07
3.0
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
74
1.08
0.07
5.1
1.4
%
60.9
63.5
—
8
74
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
84
0.83
0.07
1.1
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
89
1.13
0.07
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
158
1.08
0.06
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
192
0.94
0.05
1.2
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
100
1.10
0.05
4.0
3.2
%
55.1
56.9
0.14
11
100
(1761482) Bacteria [#/volume] in Urine by Culture
15
140
1.07
0.04
5.4
4.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
91
1.10
0.04
1.0
1.1
—
15.4
—
0
8
(4035726)
49
498
0.98
0.01
1.5
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
80
793
1.01
0.01
1.4
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
104
1.06
0.01
1.4
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
591
5903
1.01
0.00
4.4
4.0
mmol/l
1.5
1.5
0.77
551
5497
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
96
1.04
0.00
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
127
1.02
0.00
2.5
2.3
ug/min
29.6
119.6
—
8
81
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
68.6
—
0
7
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.4
—
0
5
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
260
1.00
0.00
1.8
1.8
mg/l
3.6
3.1
0.20
21
189
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.7
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
16.0
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
1.2
1.7
g/l
1.0
1.0
—
5
52
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
9
0.00
0.00
0.0
2.3
—
1.2
—
0
9
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.8
—
0
6
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
6
0.00
0.00
0.0
3.7
—
39.3
—
0
6
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
101.2
—
0
8
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
5.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
61
0.98
0.00
1.2
2.9
pg
32.2
32.4
—
6
61
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
6
0.00
0.00
0.0
2.2
—
321.0
—
0
6
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4306422)
9
94
0.96
0.00
1.4
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_DEFORMDORSONAS and mortality.

Females

Parameter HR [95% CI] p-value
M13_DEFORMDORSONAS 1.568 [1.23, 2.0] < 0.001
Birth year 0.997 [0.99, 1.01] 0.519

During the follow-up period (1.1.1998 — 31.12.2019), 118 out of 546 females with M13_DEFORMDORSONAS died.

Males

Parameter HR [95% CI] p-value
M13_DEFORMDORSONAS 1.136 [0.78, 1.64] 0.5
Birth year 0.984 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 373 males with M13_DEFORMDORSONAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_DEFORMDORSONAS.

N-year risk Females Males
1 0.184% 0.208%
5 1.08% 1.234%
10 2.375% 3.06%
15 4.839% 5.699%
20 8.709% 9.628%

Relationships between endpoints

↥

Index endpoint: M13_DEFORMDORSONAS – Other specified/unspecified deforming dorsopathies

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data